ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $379 | -0.5% | 21,138 | +1.2% | 0.03% | -15.8% |
| Q1 2023 | $381 | -38.8% | 20,886 | -30.6% | 0.04% | -50.6% |
| Q4 2022 | $623 | -99.8% | 30,108 | +204.5% | 0.08% | +102.6% |
| Q2 2022 | $251,000 | -49.7% | 9,888 | -37.5% | 0.04% | -43.3% |
| Q1 2022 | $499,000 | +98.8% | 15,809 | +154.6% | 0.07% | +109.4% |
| Q4 2021 | $251,000 | -53.1% | 6,210 | -80.1% | 0.03% | -64.0% |
| Q3 2020 | $535,000 | +129.6% | 31,217 | +231.5% | 0.09% | -31.5% |
| Q2 2020 | $233,000 | -49.6% | 9,417 | -71.7% | 0.13% | +12.1% |
| Q1 2020 | $462,000 | -35.2% | 33,319 | -52.8% | 0.12% | +39.8% |
| Q4 2019 | $713,000 | +99.2% | 70,619 | +79.4% | 0.08% | +72.9% |
| Q3 2019 | $358,000 | +177.5% | 39,354 | +142.3% | 0.05% | +242.9% |
| Q2 2019 | $129,000 | -25.4% | 16,243 | +17.3% | 0.01% | -22.2% |
| Q1 2019 | $173,000 | – | 13,851 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |